JPY 113400.0
(1.16%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 29.09 Billion | 19.42 Billion | 26.17 Billion | 28.77 Billion | 14.12 Billion | 13.4 Billion |
Net Income | 15.93 Billion | 13.36 Billion | 12.28 Billion | 13.28 Billion | 10.89 Billion | 9.81 Billion |
Depreciation & Amortization | 4.93 Billion | 4.51 Billion | 4.61 Billion | 3.71 Billion | 3.05 Billion | 2.76 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 8.07 Billion | 1.52 Billion | 9.18 Billion | 11.64 Billion | 29.13 Million | 898.21 Million |
Other non-cash items | 147.8 Million | 9.88 Billion | 95.41 Million | 143.64 Million | 147.99 Million | -84.46 Million |
Investing Cash Flow | -139.48 Billion | -21.86 Billion | -25.59 Billion | -45.69 Billion | -26.82 Billion | -27.55 Billion |
Investments in PPE | -124.04 Billion | -21.76 Billion | -27.4 Billion | -49.67 Billion | -27.76 Billion | -28.21 Billion |
Acquisitions | -356 Million | - | - | - | - | - |
Investment purchases | -17.26 Billion | -356.82 Million | -704.7 Million | -309.66 Million | -685.15 Million | -232.74 Million |
Sales/Maturities of investments | 1.85 Billion | 163.63 Million | 2.37 Billion | 4.24 Billion | 1.52 Billion | 860.97 Million |
Other Investing Activities | -24.29 Million | 95.65 Million | 138.11 Million | 39.16 Million | 97.88 Million | 29.69 Million |
Financing Cash Flow | 104.33 Billion | 2.35 Billion | -4.73 Billion | 45.39 Billion | 16.13 Billion | 13.99 Billion |
Debt repayment | -70 Billion | -4.8 Billion | -17.6 Billion | -23.8 Billion | -5.62 Billion | -11.78 Billion |
Dividends payments | -14.19 Billion | -12.87 Billion | -13.09 Billion | -11.94 Billion | -11.05 Billion | -9.23 Billion |
Common Stock Repurchased | - | - | -5 Billion | -57.34 Billion | -13.19 Billion | -23.23 Billion |
Common Stock Issuance | 46.77 Billion | 10.43 Billion | 5 Billion | 33.54 Billion | 13.19 Billion | 11.44 Billion |
Other Financing Activities | 48.53 Billion | 5.76 Billion | 25.95 Billion | 104.94 Billion | 32.82 Billion | 46.79 Billion |
Accounts receivables | -2.67 Billion | -177.07 Million | -13.21 Million | 791.68 Million | -957.66 Million | -33.26 Million |
Accounts payables | 366.03 Million | -656.8 Million | 222.34 Million | 496.11 Million | -136.28 Million | 14.51 Million |
Inventory | - | - | 12.23 Million | -5.34 Million | -10.33 Million | 213.76 Million |
Other working capital | 10.74 Billion | 2.36 Billion | 8.96 Billion | 10.35 Billion | 1.13 Billion | 703.19 Million |
Cash at beginning of period | 85.1 Billion | 41.46 Billion | 86.32 Billion | 53.49 Billion | 41.19 Billion | 28.4 Billion |
Cash at end of period | 79.06 Billion | 41.36 Billion | 82.16 Billion | 81.97 Billion | 44.62 Billion | 28.24 Billion |
Capital Expenditure | -124.04 Billion | -21.76 Billion | -27.4 Billion | -49.67 Billion | -27.76 Billion | -28.21 Billion |
Effect of forex changes on cash | -93.02 Million | 1000.00 | 1000.00 | - | 2000.00 | 1000.00 |
Net cash flow / Change in cash | -6.04 Billion | -93.76 Million | -4.15 Billion | 28.48 Billion | 3.43 Billion | -161.39 Million |
Free Cash Flow | -94.94 Billion | -2.34 Billion | -1.22 Billion | -20.89 Billion | -13.64 Billion | -14.81 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 4.34 Billion | 4.34 Billion | 3.62 Billion | 14.66 Billion | 3.62 Billion | 13.36 Billion |
Depreciation & Amortization | 1.44 Billion | 1.44 Billion | 1.06 Billion | 3.81 Billion | 1.05 Billion | 4.51 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 2.56 Billion | 2.56 Billion | 1.28 Billion | 4.1 Billion | 1.28 Billion | 1.52 Billion |
Other non-cash items | 177.45 Million | 177.45 Million | 49 Million | -467 Million | 56 Million | 9.88 Billion |
Investing Cash Flow | -64.37 Billion | -64.37 Billion | -5.36 Billion | -24.76 Billion | -5.36 Billion | -21.86 Billion |
Investments in PPE | -113.13 Billion | - | -10.91 Billion | - | - | -21.76 Billion |
Acquisitions | - | - | -413 Thousand | -356 Million | -413 Thousand | - |
Investment purchases | -16.76 Billion | - | - | - | - | -356.82 Million |
Sales/Maturities of investments | 140.29 Million | - | - | - | - | 163.63 Million |
Other Investing Activities | -64.37 Billion | -64.37 Billion | -5.36 Billion | -24.4 Billion | -5.36 Billion | 95.65 Million |
Financing Cash Flow | 51.63 Billion | 51.63 Billion | 531.5 Million | 4.36 Billion | 531.5 Million | 2.35 Billion |
Debt repayment | -64 Billion | - | -8 Billion | -12.7 Billion | - | -4.8 Billion |
Dividends payments | -3.62 Billion | -3.62 Billion | -3.46 Billion | -13.39 Billion | -3.46 Billion | -12.87 Billion |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 46.77 Billion | - | - | - | - | 10.43 Billion |
Other Financing Activities | 55.26 Billion | 55.26 Billion | 3.99 Billion | 5.06 Billion | 3.99 Billion | 5.76 Billion |
Accounts receivables | -311.29 Million | -311.29 Million | 52 Million | -398 Million | 52 Million | -177.07 Million |
Accounts payables | 337.07 Million | - | 28.95 Million | - | - | -656.8 Million |
Inventory | - | - | - | - | - | - |
Other working capital | 2.87 Billion | 2.87 Billion | 1.23 Billion | 4.5 Billion | 1.23 Billion | 2.36 Billion |
Cash at beginning of period | 43.74 Billion | - | 41.36 Billion | 83.48 Billion | 376.99 Thousand | 41.46 Billion |
Cash at end of period | 35.31 Billion | -4.21 Billion | 43.74 Billion | 85.1 Billion | 1.18 Billion | 41.36 Billion |
Capital Expenditure | -113.13 Billion | - | -10.91 Billion | - | - | -21.76 Billion |
Effect of forex changes on cash | - | - | - | -93.02 Million | - | 1000.00 |
Net cash flow / Change in cash | -8.42 Billion | -4.21 Billion | 2.37 Billion | 1.62 Billion | 1.18 Billion | -93.76 Million |
Free Cash Flow | -104.59 Billion | 8.53 Billion | -4.89 Billion | 22.11 Billion | 6.01 Billion | -2.34 Billion |
6216
TRANSCHEM
NEWLIGHT
BAKPF
BROOKS
GB00BL9YR756